. 2021 Nov 3;13:8307–8316. doi: 10.2147/CMAR.S328309

Table 3.

Three- and Five-Year Survival Rates of Different Stages, Chemotherapy Regimens, or Tumor Sizes and Efficacy After All Treatments

All Patients	Cases	3-Yr SR	χ²	P value	5-Yr SR	χ²	P value
All Patients	120	82.5%	χ²	P value	70.8%	χ²	P value
Stage
IIb stage	n =65	83.1%	2.730	0.098	69.2%	0.597	0.440
IIIb stage	n =34	70.6%	2.730	0.098	64.7%	0.597	0.440
Chemotherapy
Regimen
TP	n =62	85.5%	1.177	0.278	75.8%	1.424	0.233
TL	n =58	77.6%	1.177	0.278	65.5%	1.424	0.233
Tumor Size
<5 cm	n =50	88.0%	2.465	0.116	84.0%	6.906	0.009
≥5 cm	n =70	77.1%	2.465	0.116	61.4%	6.906	0.009
Efficacy
CR	n =63	87.3%	2.730	0.098	71.1%	0.168	0.682
PR	n =56	75.0%	2.730	0.098	69.6%	0.168	0.682

Abbreviations: TP, paclitaxel plus cisplatin; TL, paclitaxel plus loplatin; CR, complete response; PR, partial response; SR, survival rate.